- Corporate Officers - P
- Parker Geoffrey M.
Insider Trading History of Parker Geoffrey M.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Parker Geoffrey M. since 2015.
This trader's CIK number is 1491874.
At the time of last reporting, Parker Geoffrey M. was the Director of Perrigo Co Plc. (stock ticker symbol PRGO).
Also see all insider trading activities at Perrigo Co Plc.
Note that in the past
Parker Geoffrey M. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Allogene Therapeutics, Inc. (ALLO) by Parker Geoffrey M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | ALLO | 0 | $0 | 4,361 | $7,544 | 0 | $0 |
2024 | ALLO | 190 | $683 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tricida, Inc. (TCDA) by Parker Geoffrey M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | TCDA | 55,000 | $1,298,818 | 0 | $0 | 0 | $0 |
2019 | TCDA | 50,000 | $1,662,813 | 0 | $0 | 54,347 | $99,998 |
2018 | TCDA | 65,000 | $1,288,600 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Perrigo Co Plc (PRGO) by Parker Geoffrey M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | PRGO | 7,875 | $195,348 | 0 | $0 | 9,904 | $257,603 |
2024 | PRGO | 0 | $0 | 0 | $0 | 8,764 | $264,848 |
2023 | PRGO | 15,000 | $520,910 | 0 | $0 | 7,778 | $255,585 |
2022 | PRGO | 0 | $0 | 0 | $0 | 6,599 | $254,523 |
2021 | PRGO | 7,500 | $287,487 | 0 | $0 | 5,804 | $249,339 |
2020 | PRGO | 0 | $0 | 0 | $0 | 6,054 | $319,409 |
2019 | PRGO | 0 | $0 | 0 | $0 | 3,971 | $196,763 |
2018 | PRGO | 3,000 | $196,058 | 0 | $0 | 4,265 | $312,283 |
2017 | PRGO | 0 | $0 | 0 | $0 | 1,948 | $147,093 |
2016 | PRGO | 2,500 | $221,875 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Viracta Therapeutics, Inc. (SNSS) by Parker Geoffrey M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | SNSS | 65,745 | $43,758 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Anacor Pharmaceuticals Inc (ANAC) by Parker Geoffrey M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | ANAC | 3,000 | $157,305 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Chemocentryx, Inc. (CCXI) by Parker Geoffrey M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | CCXI | 0 | $0 | 0 | $0 | 20,226 | $180,250 |
2021 | CCXI | 0 | $0 | 31,910 | $1,804,970 | 0 | $0 |
2020 | CCXI | 0 | $0 | 30,000 | $1,092,450 | 7,724 | $0 |
2019 | CCXI | 0 | $0 | 12,815 | $153,805 | 58,421 | $300,000 |
2018 | CCXI | 0 | $0 | 0 | $0 | 12,912 | $0 |
2017 | CCXI | 0 | $0 | 0 | $0 | 20,362 | $0 |
2016 | CCXI | 60,000 | $253,920 | 0 | $0 | 11,795 | $0 |
2015 | CCXI | 20,000 | $144,929 | 13,513 | $101,509 | 27,027 | $0 |
Yearly summary of insider trading at Better Therapeutics, Inc. (BTTX) by Parker Geoffrey M.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | BTTX | 988,055 | $750,067 | 0 | $0 | 0 | $0 |
2022 | BTTX | 40,000 | $68,410 | 0 | $0 | 0 | $0 |
2021 | BTTX | 20,000 | $98,800 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Parker Geoffrey M.:
1. Allogene Therapeutics, Inc. (ALLO)
2. Tricida, Inc. (TCDA)
3. Perrigo Co Plc (PRGO)
4. Viracta Therapeutics, Inc. (SNSS)
5. Anacor Pharmaceuticals Inc (ANAC)
6. Chemocentryx, Inc. (CCXI)
7. Better Therapeutics, Inc. (BTTX)
Table 1. Insider trading of Allogene Therapeutics, Inc. (ALLO) by Parker Geoffrey M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-02-03 | ALLO | Sale | 4,361 | 1.73 | 7,544 |
2024-01-30 | ALLO | Buy | 190 | 3.60 | 683 |
Table 2. Insider trading of Tricida, Inc. (TCDA) by Parker Geoffrey M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-12-10 | TCDA | Buy | 15,000 | 6.78 | 101,700 |
2020-05-11 | TCDA | Buy | 32,258 | 29.92 | 965,159 |
2020-05-12 | TCDA | Buy | 2,742 | 30.88 | 84,659 |
2020-03-10 | TCDA | Buy | 5,000 | 29.46 | 147,300 |
2019-11-18 | TCDA | Buy | 19,055 | 34.28 | 653,205 |
2019-11-19 | TCDA | Buy | 945 | 34.72 | 32,810 |
2019-09-03 | TCDA | Option Ex | 54,347 | 1.84 | 99,998 |
2019-08-12 | TCDA | Buy | 18,053 | 32.10 | 579,501 |
2019-08-13 | TCDA | Buy | 11,947 | 33.26 | 397,297 |
2018-11-13 | TCDA | Buy | 5,000 | 29.72 | 148,600 |
2018-07-02 | TCDA | Buy | 60,000 | 19.00 | 1,140,000 |
Table 3. Insider trading of Perrigo Co Plc (PRGO) by Parker Geoffrey M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-08-18 | PRGO | Buy | 4,375 | 22.97 | 100,498 |
2025-05-14 | PRGO | Option Ex | 9,904 | 26.01 | 257,603 |
2025-05-12 | PRGO | Buy | 3,500 | 27.10 | 94,850 |
2024-05-15 | PRGO | Option Ex | 8,764 | 30.22 | 264,848 |
2023-06-13 | PRGO | Buy | 10,000 | 33.06 | 330,640 |
2023-05-17 | PRGO | Option Ex | 7,778 | 32.86 | 255,585 |
2023-03-06 | PRGO | Buy | 5,000 | 38.05 | 190,270 |
2022-05-17 | PRGO | Option Ex | 6,599 | 38.57 | 254,523 |
2021-12-16 | PRGO | Buy | 5,000 | 36.85 | 184,270 |
2021-05-07 | PRGO | Option Ex | 5,804 | 42.96 | 249,339 |
2021-03-17 | PRGO | Buy | 2,500 | 41.29 | 103,217 |
2020-05-15 | PRGO | Option Ex | 6,054 | 52.76 | 319,409 |
2019-05-15 | PRGO | Option Ex | 3,971 | 49.55 | 196,763 |
2018-11-12 | PRGO | Buy | 3,000 | 65.35 | 196,058 |
2018-06-06 | PRGO | Option Ex | 4,265 | 73.22 | 312,283 |
2017-07-20 | PRGO | Option Ex | 1,948 | 75.51 | 147,093 |
2016-11-21 | PRGO | Buy | 2,500 | 88.75 | 221,875 |
Table 4. Insider trading of Viracta Therapeutics, Inc. (SNSS) by Parker Geoffrey M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-12-08 | SNSS | Buy | 3,146 | 3.87 | 12,159 |
2016-12-09 | SNSS | Buy | 594 | 3.90 | 2,317 |
2016-05-26 | SNSS | Buy | 9,500 | .47 | 4,455 |
2016-05-24 | SNSS | Buy | 30,000 | .46 | 13,890 |
2016-05-25 | SNSS | Buy | 22,505 | .49 | 10,937 |
Table 5. Insider trading of Anacor Pharmaceuticals Inc (ANAC) by Parker Geoffrey M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-03-23 | ANAC | Buy | 3,000 | 52.44 | 157,305 |
Table 6. Insider trading of Chemocentryx, Inc. (CCXI) by Parker Geoffrey M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-05-20 | CCXI | Option Ex | 7,726 | .00 | 0 |
2022-05-02 | CCXI | Option Ex | 12,500 | 14.42 | 180,250 |
2021-03-04 | CCXI | Sale | 1,910 | 60.20 | 114,980 |
2021-03-05 | CCXI | Sale | 30,000 | 56.33 | 1,689,990 |
2020-05-23 | CCXI | Option Ex | 7,724 | .00 | 0 |
2020-03-23 | CCXI | Sale | 30,000 | 36.41 | 1,092,450 |
2019-12-02 | CCXI | Option Ex | 31,990 | 6.00 | 191,940 |
2019-05-30 | CCXI | Option Ex | 18,010 | 6.00 | 108,060 |
2019-05-30 | CCXI | Sale | 12,815 | 12.00 | 153,805 |
2019-05-21 | CCXI | Option Ex | 8,421 | .00 | 0 |
2018-05-25 | CCXI | Option Ex | 12,912 | .00 | 0 |
2017-05-26 | CCXI | Option Ex | 20,362 | .00 | 0 |
2016-05-21 | CCXI | Option Ex | 11,795 | .00 | 0 |
2016-05-13 | CCXI | Buy | 40,000 | 4.04 | 161,400 |
2016-01-11 | CCXI | Buy | 20,000 | 4.63 | 92,520 |
2015-12-11 | CCXI | Buy | 4,621 | 7.30 | 33,724 |
2015-12-10 | CCXI | Buy | 15,379 | 7.23 | 111,205 |
2015-05-27 | CCXI | Sale | 13,513 | 7.51 | 101,509 |
2015-05-22 | CCXI | Option Ex | 27,027 | .00 | 0 |
Table 7. Insider trading of Better Therapeutics, Inc. (BTTX) by Parker Geoffrey M.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-07-27 | BTTX | Buy | 685,025 | .73 | 500,068 |
2023-04-10 | BTTX | Buy | 303,030 | .82 | 249,999 |
2022-06-13 | BTTX | Buy | 25,000 | 1.45 | 36,175 |
2022-03-29 | BTTX | Buy | 15,000 | 2.15 | 32,235 |
2021-12-14 | BTTX | Buy | 20,000 | 4.94 | 98,800 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Parker Geoffrey M.
(Director of Perrigo Co Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.